CA1067406A - Stabilized oral poliovaccine and stabilizing medium therefor - Google Patents

Stabilized oral poliovaccine and stabilizing medium therefor

Info

Publication number
CA1067406A
CA1067406A CA266,768A CA266768A CA1067406A CA 1067406 A CA1067406 A CA 1067406A CA 266768 A CA266768 A CA 266768A CA 1067406 A CA1067406 A CA 1067406A
Authority
CA
Canada
Prior art keywords
cystine
poliovirus
tris
stabilizing
improved
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA266,768A
Other languages
English (en)
French (fr)
Inventor
Adolf Von Seefried
Joong H. Chun
Hildegarde M.G. Macmorine
Original Assignee
Connaught Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Connaught Laboratories Ltd filed Critical Connaught Laboratories Ltd
Priority to CA266,768A priority Critical patent/CA1067406A/en
Priority to NO773378A priority patent/NO773378L/no
Priority to FI773015A priority patent/FI57534C/fi
Priority to DE19772747662 priority patent/DE2747662A1/de
Priority to SE7712473A priority patent/SE426440B/xx
Priority to DE2752725A priority patent/DE2752725C2/de
Priority to DK526477A priority patent/DK145175C/da
Priority to BE182976A priority patent/BE861265A/xx
Priority to AT850077A priority patent/AT351161B/de
Priority to NL7713087A priority patent/NL7713087A/xx
Priority to FR7735923A priority patent/FR2371927A1/fr
Application granted granted Critical
Publication of CA1067406A publication Critical patent/CA1067406A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A61K39/13—Poliovirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
CA266,768A 1976-11-29 1976-11-29 Stabilized oral poliovaccine and stabilizing medium therefor Expired CA1067406A (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
CA266,768A CA1067406A (en) 1976-11-29 1976-11-29 Stabilized oral poliovaccine and stabilizing medium therefor
NO773378A NO773378L (no) 1976-11-29 1977-10-04 Baerer for fremstilling av lagringsstabil poliovaksine
FI773015A FI57534C (fi) 1976-11-29 1977-10-11 Foerfarande foer foerbaettrandet av stabiliteten vid rumstemperatur hos ett oralt poliovirusvaccin av typen 1, 2 eller 3
DE19772747662 DE2747662A1 (de) 1976-11-29 1977-10-24 Poliomyelitis-vaccine
SE7712473A SE426440B (sv) 1976-11-29 1977-11-03 Suspenderingsmedium for poliovirusvaccin
DE2752725A DE2752725C2 (de) 1976-11-29 1977-11-25 Stabilisierter Poliomyelitis-Impfstoff und Verfahren zu seiner Herstellung
DK526477A DK145175C (da) 1976-11-29 1977-11-28 Suspensionsmedium til anvendelse ved fremstilling af en stabiliseret poliomyelitisvaccine samt fremgangsmaade til fremstilling af dette medium
BE182976A BE861265A (fr) 1976-11-29 1977-11-28 Nouveau vaccin antipoliomyelitique stabilise et sa composition stabilisante
AT850077A AT351161B (de) 1976-11-29 1977-11-28 Verfahren zur herstellung einer poliomyelitis - vaccine, suspendiermedium zum einsatz in diesem verfahren und herstellung des suspendier- mediums
NL7713087A NL7713087A (nl) 1976-11-29 1977-11-28 Werkwijze voor het bereiden van een poliovirus- -vaccin.
FR7735923A FR2371927A1 (en) 1976-11-29 1977-11-29 Anti:poliomyelitis vaccine contg. attenuated viruses - is stabilised by suspending in tris-hydroxy-methyl-amino-methane and L-cystine opt. with acid hydrolysed gelatin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA266,768A CA1067406A (en) 1976-11-29 1976-11-29 Stabilized oral poliovaccine and stabilizing medium therefor

Publications (1)

Publication Number Publication Date
CA1067406A true CA1067406A (en) 1979-12-04

Family

ID=4107389

Family Applications (1)

Application Number Title Priority Date Filing Date
CA266,768A Expired CA1067406A (en) 1976-11-29 1976-11-29 Stabilized oral poliovaccine and stabilizing medium therefor

Country Status (10)

Country Link
AT (1) AT351161B (de)
BE (1) BE861265A (de)
CA (1) CA1067406A (de)
DE (2) DE2747662A1 (de)
DK (1) DK145175C (de)
FI (1) FI57534C (de)
FR (1) FR2371927A1 (de)
NL (1) NL7713087A (de)
NO (1) NO773378L (de)
SE (1) SE426440B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4252792A (en) 1979-09-21 1981-02-24 Douglas Industries, Inc. Injectable rabies vaccine composition and method for preparing same
EP0049296B1 (de) * 1980-10-02 1985-03-27 Schering Corporation Injizierbare Tollwutimpfstoffzusammensetzung und Verfahren zu ihrer Herstellung
NL8102740A (nl) * 1981-06-05 1983-01-03 Nederlanden Staat Virusvaccins en werkwijze ter bereiding daarvan.
US5360736A (en) * 1992-06-04 1994-11-01 Merck & Co., Inc. Process for attenuated varicella zoster virus vaccine production

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE665076A (de) * 1963-12-23 1965-12-08

Also Published As

Publication number Publication date
DE2752725C2 (de) 1987-02-12
FR2371927B1 (de) 1981-06-19
DE2747662A1 (de) 1978-06-01
DK526477A (da) 1978-05-30
FI773015A7 (fi) 1978-05-30
FI57534B (fi) 1980-05-30
DK145175C (da) 1983-02-28
FR2371927A1 (en) 1978-06-23
SE426440B (sv) 1983-01-24
NL7713087A (nl) 1978-05-31
FI57534C (fi) 1980-09-10
DE2752725A1 (de) 1978-06-15
ATA850077A (de) 1978-12-15
SE7712473L (sv) 1978-05-30
BE861265A (fr) 1978-03-16
NO773378L (no) 1978-05-30
DK145175B (da) 1982-09-27
AT351161B (de) 1979-07-10

Similar Documents

Publication Publication Date Title
US6884422B1 (en) Freeze-dried hepatitis A attenuated live vaccine and its stabilizer
ES2242201T3 (es) Estabilizadores para vacunas vivas.
US6039958A (en) Stabilized live vaccine
JP6253161B2 (ja) 乾燥された生物学的材料を安定化するための方法及び組成物
JPH046689B2 (de)
JPH02503266A (ja) ウイルスの保存
US20080241187A1 (en) Stabilization of viral compositions
CA2065023A1 (en) Stabilized vaccine compositions
AU2018236897B2 (en) Compositions and methods for live, attenuated alphavirus formulations
CA1067406A (en) Stabilized oral poliovaccine and stabilizing medium therefor
AU2001295672B2 (en) Vaccine composition and stabilisation method
Siegert et al. The pyrogens of myxoviruses I. Induction of hyperthermia and its tolerance
JPH06234659A (ja) 安定化生ワクチン
GB1564998A (en) Vaccine and stabilizing solution therefor
Newman et al. Stabilising oral poliovaccine at high ambient temperatures
Pipkin et al. Studies on the loss of infectivity of live type 3 poliovaccine on storage
Wolf et al. Infectious pancreatic necrosis virus: lyophilization and subsequent stability in storage at 4 C
WO2021020446A1 (ja) 単純ヘルペスウイルスを含む組成物
Golden et al. Enhancement of the infectivity titer of adenovirus type 8
Allison et al. Thermal inactivation of Pichinde virus
CN120899929A (zh) 口蹄疫抗原保护剂及其制备方法与应用
Adams et al. Factors affecting the stability of transmissible enteritis virus of turkeys
CN115518149A (zh) 一种四价登革灭活疫苗
Mirchamsy et al. Stabilizing effect of magnesium chloride and sucrose on Sabin live polio vaccine
CN119055764A (zh) 一种抗原保护剂及其应用